Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE005580 |
ID: | TCMBANKHE005580 |
植物拉丁名: |
|
功能与主治: | To transform concretion and disperse accumulation, kill worms, interrupt malaria./Concretion and conglomeration, lump glomus, worm accumulation, meat-type food accumulation, cold pain in heart and abdomen, malaria, dysentery. |
药用植物名: | 阿魏 |
药用部位: | balsam |
药味: | Warm; Pungent; Bitter |
经络: | Spleen; Stomach; Liver |
治疗类型: | 消食 |
TCM_ID_id: | 4866 |
TCMSP_id: | 1 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN002673 | delta(3)-carene | C10H16 | 136.23 g/mol | CC1=CCC2C(C1)C2(C)C | |
| TCMBANKIN004282 | undecyl sulfonyl aceticacid | C13H26O4S | CCCCCCCCCCCS(=O)(=O)CC(=O)O | ||
| TCMBANKIN006895 | conferone | C24H28O4 | 380.5 g/mol | CC1=CCC2C(C(=O)CCC2(C1COC3=CC4=C(C=C3)C=CC(=O)O4)C)(C)C | |
| TCMBANKIN010115 | assafoetidin | C24H30O4 | 382.5 g/mol | CC1=C(C(C(CC1)O)(C)C)CCC(=CCOC2=CC3=C(C=C2)C=CC(=O)O3)C | |
| TCMBANKIN011815 | confertifolin | C15H22O2 | 234.33 g/mol | CC1(CCCC2(C1CCC3=C2COC3=O)C)C | |
| TCMBANKIN019289 | galbanicacid | C24H30O5 | 398.5 g/mol | CC1CCC(=C(C)C)C(C1(C)COC2=CC3=C(C=C2)C=CC(=O)O3)CCC(=O)O | |
| TCMBANKIN019587 | conferol | C24H30O4 | 382.5 g/mol | CC1=CCC2C(C(CCC2(C1COC3=CC4=C(C=C3)C=CC(=O)O4)C)O)(C)C | |
| TCMBANKIN029374 | 1-(1-Methyl thiopropyl)-1-propenyl disulfide | AC1NSYM7; 1-methylsulfanyl-1-(prop-1-enyldisulfanyl)propane; 1-(1-methyl thiopropyl)-1-propenyl disulfide | C7H14S3 | 194.42 | CCC(SC)SSC=CC |
| TCMBANKIN037069 | polyanthinin | C27H34O5 | CC(=O)OC1CCC2(C(C(=C)CCC2(C1(C)C)C)COC3=CC4=C(C=C3)C=CC(=O)O4)C | ||
| TCMBANKIN037308 | β-Eudesmol | 2-Naphthaleneethanol, decahydro-alpha,alpha,4a-trimethyl-8-methylene-; SCHEMBL12633040; beta-eudesmol; 2-[(2R,4aR,8aS)-4a-methyl-8-methylene-decalin-2-yl]propan-2-ol; 17790_FLUKA; 2-Naphthalenemethanol, decahydro-8-methylene-alpha,alpha,4a-trimethyl-, (2R-(2-alpha,4a-alpha,8a-beta)-; 2-[(2R,4aR,8aS)-4a-methyl-8-methylidene-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]propan-2-ol; 3beta-(1-Hydroxy-1-methylethyl)-5-methylene-8abeta-methyldecahydronaphthalene; Beta- Eudesmol; (2R,4aR,8aS)-Decahydro-8-methylene-alpha,alpha,4a-trimethyl-2-naphthylmethanol; β- eudesmol; Eudesm-4(14)-en-11-ol (8CI); beta-Selinenol; rel-2-[(2R,4aR,8aS)-4a-methyl-8-methylenedecahydronaphthalen-2-yl]propan-2-ol; 2-naphthalenemethanol, decahydro-alpha,alpha,4a-trimethyl-8-methylene-, (2R,4aR,8aS)-; C09664; InChI=1/C15H26O/c1-11-6-5-8-15(4)9-7-12(10-13(11)15)14(2,3)16/h12-13,16H,1,5-10H2,2-4H3/t12-,13+,15-/m1/s; beta-eudesmol ; 2-[(2R,4aR,8aS)-4a-methyl-8-methylene-2-decalinyl]propan-2-ol; AC1NSVC6; 2-[(2R,4aR)-4a-methyl-8-methylidene-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]propan-2-ol; beta-Eudesmol; beta- eudesmol; 473-15-4; 4(15)-eudesmen-11-ol | 222.37 | ||
| TCMBANKIN037398 | Farnesiferol C | C24H30O4 | 382.5 g/mol | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(O[C@]12[H])[C@]([H])(C([H])([H])C([H])([H])\C(=C([H])\C([H])([H])Oc3c([H])c(OC(=O)C([H])=C4[H])c4c([H])c3[H])\C([H])([H])[H])C2(C([H])([H])[H])C([H])([H])[H ] | |
| TCMBANKIN038204 | ferulic acid | (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; caffeic acid 3-methyl ether; ferulicacid; A803063; (E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoate; CJ-00500; ZB002373; ferulate; CHEBI:29749; (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; 3-Methoxy-4-hydroxy-trans-cinnamate; (E)-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enoate; Ferulic Acid; AC1NUT2L; ferulic acid | C10H10O4 | 194.18 | COC1=C(C=CC(=C1)C=CC(=O)O)[O-] |
| TCMBANKIN038274 | Farnesiferol B | C24H30O4 | 382.493 | C1([H])([H])C([H])([H])C(=C([H])[H])[C@]([H])(C([H])([H])C([H])([H])\C(=C([H])\C([H])([H])Oc2c([H])c(OC(=O)C([H])=C3[H])c3c([H])c2[H])\C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[H] | |
| TCMBANKIN040021 | farnesiferol a | 7-{[(1S,4AS,6R,8AR)-6-HYDROXY-5,5,8A-TRIMETHYL-2-METHYLIDENE-HEXAHYDRO-1H-NAPHTHALEN-1-YL]METHOXY}CHROMEN-2-ONE; SCHEMBL12362728; 7-[[(1S,4aS,6R,8aR)-6-hydroxy-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]methoxy]chromen-2-one; 8YC9944MPJ; UNII-8YC9944MPJ; Farnesiferol A, >=85% (NMR); 511-33-1; DTXSID00199105; ZINC4081322; Farnesiferol A; Mogoltadin; NCGC00385155-01!7-[[(1S,4aS,6R,8aR)-6-hydroxy-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]methoxy]chromen-2-one; MolPort-002-525-707; CHEMBL1078138; AC1OF2BZ | C24H30O4 | 382.5 g/mol | CC1(C2CCC(=C)C(C2(CCC1O)C)COC3=CC4=C(C=C3)C=CC(=O)O4)C |
| TCMBANKIN040148 | Assafoetidnol B | 456.5 g/mol | |||
| TCMBANKIN043227 | Kamolonol | 398.5 g/mol | |||
| TCMBANKIN043729 | Samarcandin | 400.5 g/mol | |||
| TCMBANKIN046249 | camphene | CHEMBL506889; CJ-04639; (-)-camphene; (-)-Camphene, technical grade, 75% (90% as camphene and fenchene); L-Camphene; DSSTox_RID_81702; (1S,4R)-2,2-dimethyl-3-methylenebicyclo[2.2.1]heptane; Bicyclo(2.2.1)heptane, 2,2-dimethyl-3-methylene-, (1S)-; (1S)-2,2-Dimethyl-3-methylenebicyclo(2.2.1)heptane; DSSTox_CID_26538; FCH1121419; (1S,4R)-2,2-dimethyl-3-methylidenebicyclo[2.2.1]heptane; 5794/4/7; C06305; (-) camphene; ZB015525; CC-00037; M5YAV509FN; UNII-G3VG94Z26E component CRPUJAZIXJMDBK-BDAKNGLRSA-N; DTXSID3046538; ZINC968230; CHEBI:89; (1S,4R)-camphene; (-)-Comphene; cam phene; DSSTox_GSID_46538; NCGC00166100-01; (-)-(1S,4R)-camphene; Bicyclo(2.2.1)heptane, 2,2-dimethyl-3-methylene-, (1S,4R)-; CAS-5794-04-7; EINECS 227-337-8; UNII-M5YAV509FN; CRPUJAZIXJMDBK-BDAKNGLRSA-N; (1S)-2,2-Dimethyl-3-methylenebicyclo[2.2.1]heptane; Tox21_112314 | C10H16 | 136.23 g/mol | CC1(C2CCC(C2)C1=C)C |
| TCMBANKIN049330 | assafoetidnol a | C24H30O5 | 398.5 g/mol | CC1(C(CCC2(C1C(CC(=C)C2COC3=CC4=C(C=C3)C=CC(=O)O4)O)C)O)C | |
| TCMBANKIN050441 | Neveskone | ||||
| TCMBANKIN058816 | beta-myrcene | 7-Methyl-3-methylene-octa-1,6-diene; DSSTox_RID_77883; Q-201417; CJ-23958; Myrcene, >=95%, stabilized, FCC, FG; A805060; MYRCENE, TECH; 123-35-3; STL477735; FEMA 2762; AN-22914; beta-geraniolene; LS-678; 7-Methyl-3-methylene-1,6-octadiene (myrcene); AK116901; V0542; AI3-00738; .beta.-Myrcene; 7-Methyl-3-methylene-1,6-octadiene (beta -myrcene); Myrcene, analytical standard; NCGC00254252-01; NSC-406264; ST24029965; 7-?Methyl-?3-?methylene-?1,6-?octadiene; RP20298; C06074; NCGC00091420-02; CHEBI:17221; AC1Q1NVC; Tox21_300351; MYRCENE; 2153-31-3; DSSTox_CID_5692; Jsp001569; FEMA No. 2762; FCH1116940; beta -mircene; beta -myrcene; 7-methyl-3-methylidene-octa-1,6-diene; 7-methyl-3-methylideneocta-1,6-diene; β-myrcene; Myrcene (stabilized with BHT); 2-Methyl-6-methylene-2,7-octadiene; BRN 1719990; WLN: 1Y1&U3YU1&1U1; beta- Myrcene; UAHWPYUMFXYFJY-UHFFFAOYSA-N; 7-Methyl-3-methyleneoctadiene-(1,6); 3-Methylene-7-methyl-1, 6-octadiene; NCGC00091420-01; Mycrene Solution, 1000 mg/L, 1 ml (RM, ISO Guide 34); EINECS 204-622-5; DTXSID6025692; DSSTox_GSID_25692; β- myrcene; Myrcene, technical grade; beta-Myrcene; MYRCENE 90; LMPR0102010005; Myrcene, primary pharmaceutical reference standard; NSC 406264; KS-00000WLP; HSDB 1258; AC1Q1J8N; Myrcene, .beta.-; 3M39CZS25B; beta-Myrcene (>90%); TR-003681; AJ-26651; ZINC1530331; FT-0629050; CHEMBL455491; UNII-3M39CZS25B; NSC406264; MolPort-001-792-515; beta-myrcene ; I14-17984; CCRIS 3725; 7-methyl-3-methylene-1,6 octadiene; C-34801; M0235; AKOS015904015; CAS-123-35-3; AC1L1L8S; .beta.-Geraniolene; 7-Methyl-3-methyleneocta-1,6-diene; CC-31053; b-Geraniolene; 7-Methyl-3-methylene-1,6-octadiene; 4-01-00-01108 (Beilstein Handbook Reference); Myrcene (natural); EC 204-622-5; MFCD00008908; b-Myrcene; 1,6-Octadiene, 7-methyl-3-methylene-; 3-Methylene-7-methyl-1,6-octadiene; InChI=1/C10H16/c1-5-10(4)8-6-7-9(2)3/h5,7H,1,4,6,8H2,2-3H; 1, 7-methyl-3-methylene- | C10H16 | 136.23 g/mol | CC(=CCCC(=C)C=C)C |
| TCMBANKIN059465 | 21-o-methyl toosendanpentaol | C31H52O6 | CC1(C(CCC2(C1CC(C3(C2CCC4(C3=CCC4C5CC(OC5OC)C(C(C)(C)O)O)C)C)O)C)O)C | ||
| TCMBANKIN059520 | badrakemin | C24H30O4 | CC1(C2CCC(=C)C(C2(CCC1O)C)COC3=CC4=C(C=C3)C=CC(=O)O4)C | ||
| TCMBANKIN059521 | B- pinene;pinene;T-pinene;(-)-nopinene;beta-pinene;bicyclo[3.1.1]heptane,6,6-dimethyl-2-methylene-,(1s);1-β-pinene;()-beta-Pinene;(-)- β- pinene;laevo- β- Pinene | C10H16 | 136.23 g/mol | CC1(C2CCC(=C)C1C2)C | |
| TCMBANKIN059527 | (+)-Camphene | C10H16 | 136.23 g/mol | CC1(C2CCC(C2)C1=C)C | |
| TCMBANKIN059566 | 6-O-E-Feruloylajugol | 524.57 | CC1(CC(C2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)OC(=O)C=CC4=CC(=C(C=C4)O)OC)O | ||
| TCMBANKIN059905 | p-isopropyltoluene;4-Isopropyltoluene;cymene;1-methyl-4-(1-methylethyl)benzene;Cymol;Para cymene;4-Cymol;p-cymene;Dolcymene | C10H14 | 134.22 g/mol | CC1=CC=C(C=C1)C(C)C | |
| TCMBANKIN059970 | 1, 4-Cyclohexadiene, 1-methyl-4-(1-methylethyl);crithmene;4-Isopropyl-1-methyl-1,4-cyclohexadiene;Moslene;gamma-terpinene | C10H16 | 136.23 g/mol | CC1=CCC(=CC1)C(C)C |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab